找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Oral Antidiabetics; Jochen Kuhlmann,Walter Puls Book 1996 Springer-Verlag Berlin Heidelberg 1996 Antidiabetics.Biguanides.Diabetes.Diabete

[復(fù)制鏈接]
樓主: Inspection
31#
發(fā)表于 2025-3-26 21:47:02 | 只看該作者
Sulfonylureas: Physico-chemical Properties, Analytical Methods of Determination and Bioavailabilitytic drugs include acetohexamide, acetylcarbutamide, carboxytolbutamide, carbutamide, chlorpropamide, glibenclamide, glibornuride, gliclazide, glimepiride, glipizide, gliquidone, glisoxepide, metahexamide, tolazamide and tolbutamide. The structural formulas of some of the important antidiabetic agents are given in Fig. 1.
32#
發(fā)表于 2025-3-27 02:48:17 | 只看該作者
33#
發(fā)表于 2025-3-27 06:09:17 | 只看該作者
Clinical Pharmacology of Sulfonylureasion of insulin secretion. Sulfonylureas bind to receptor-like structures on the B cell, which may be closely linked to or be part of the potassium channels (. et al. 1987; . et al. 1988; . et al. 1990). The binding capacity of different sulfonylureas reflects their ability to stimulate insulin secretion.
34#
發(fā)表于 2025-3-27 13:26:43 | 只看該作者
35#
發(fā)表于 2025-3-27 15:33:44 | 只看該作者
36#
發(fā)表于 2025-3-27 18:21:56 | 只看該作者
Chemistry and Structure-Activity Relationships of Glucosidase Inhibitorse rational design of a lead compound, when the biochemical mechanism and the structure of the enzyme are well known. In the late 1960s, when we started to look for such potent and selective inhibitors, we had to choose the random screening approach, relying mainly on testing of extracts of the culture broths of microorganisms.
37#
發(fā)表于 2025-3-28 00:55:02 | 只看該作者
0171-2004 -threatening disease. This attitude needs to be changed because the complications asso- ciated with the adult form of diabetes affect almost every organ system. The high morbidity and mortality of non-insulin-dependent diabetes mellitus (NIDDM) suggest that current treatment strategies are unsatisfa
38#
發(fā)表于 2025-3-28 03:16:18 | 只看該作者
39#
發(fā)表于 2025-3-28 06:27:52 | 只看該作者
40#
發(fā)表于 2025-3-28 13:06:16 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-11 04:24
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
达孜县| 龙陵县| 靖边县| 德州市| 靖州| 博白县| 沙雅县| 襄樊市| 东乌珠穆沁旗| 柳林县| 崇文区| 绥阳县| 铜山县| 麻城市| 怀仁县| 江北区| 灵宝市| 元氏县| 井研县| 江源县| 宜川县| 宁阳县| 平塘县| 安溪县| 巧家县| 孟连| 大洼县| 海南省| 贵德县| 浦江县| 远安县| 南安市| 曲靖市| 英吉沙县| 萍乡市| 琼海市| 平阴县| 安多县| 丁青县| 噶尔县| 绥阳县|